APO Research
Talk to an analyst

APO RESEARCH · REPORT

TACE Embolic Microspheres

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global TACE Embolic Microspheres Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025187 pages

Choose your research edition.

Industry ResearchTACE Embolic Microspheres Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal TACE Embolic Microspheres Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal TACE Embolic Microspheres Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal TACE Embolic Microspheres Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal TACE Embolic Microspheres Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global TACE Embolic Microspheres market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for TACE Embolic Microspheres is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for TACE Embolic Microspheres is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for TACE Embolic Microspheres is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for TACE Embolic Microspheres is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of TACE Embolic Microspheres include ABK Biomedical, Boston Scientific, Merit Medical, Mermaid Medical, Sirtex Medical, Terumo, Varian, Cardiolink Science and Suzhou Hengrui Medical Equipment, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global TACE Embolic Microspheres market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of TACE Embolic Microspheres and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents TACE Embolic Microspheres sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the TACE Embolic Microspheres market size, projected growth trends, production technologies, key applications, and end-use industries.

TACE Embolic Microspheres Segment by Company

ABK Biomedical

Boston Scientific

Merit Medical

Mermaid Medical

Sirtex Medical

Terumo

Varian

Cardiolink Science

Suzhou Hengrui Medical Equipment

TACE Embolic Microspheres Segment by Type

Common Embolic Microspheres

Drug-Loadable Embolic Microspheres

TACE Embolic Microspheres Segment by Application

Colorectal Cancer Liver Metastasis

Primary Liver Cancer

Others

TACE Embolic Microspheres Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global TACE Embolic Microspheres market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of TACE Embolic Microspheres and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of TACE Embolic Microspheres.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the TACE Embolic Microspheres market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of TACE Embolic Microspheres manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of TACE Embolic Microspheres in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of TACE Embolic Microspheres in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. TACE Embolic Microspheres Industry Trends Table 2. TACE Embolic Microspheres Industry Drivers Table 3. TACE Embolic Microspheres Industry Opportunities and Challenges Table 4. TACE Embolic Microspheres Industry Restraints Table 5. Global TACE Embolic Microspheres Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global TACE Embolic Microspheres Revenue Market Share by Manufacturers (2021-2026) Table 7. Global TACE Embolic Microspheres Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global TACE Embolic Microspheres Sales Market Share by Manufacturers Table 9. Global TACE Embolic Microspheres Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global TACE Embolic Microspheres Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global TACE Embolic Microspheres Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global TACE Embolic Microspheres Manufacturers, Product Type & Application Table 13. Global TACE Embolic Microspheres Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global TACE Embolic Microspheres by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Common Embolic Microspheres Table 17. Major Manufacturers of Drug-Loadable Embolic Microspheres Table 18. Global TACE Embolic Microspheres Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global TACE Embolic Microspheres Sales by Type (2021-2026) & (K Units) Table 20. Global TACE Embolic Microspheres Sales by Type (2027-2032) & (K Units) Table 21. Global TACE Embolic Microspheres Sales Market Share by Type (2021-2026) Table 22. Global TACE Embolic Microspheres Sales Market Share by Type (2027-2032) Table 23. Global TACE Embolic Microspheres Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global TACE Embolic Microspheres Revenue by Type (2021-2026) & (K Units) Table 25. Global TACE Embolic Microspheres Revenue by Type (2027-2032) & (K Units) Table 26. Global TACE Embolic Microspheres Revenue Market Share by Type (2021-2026) Table 27. Global TACE Embolic Microspheres Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Colorectal Cancer Liver Metastasis Table 29. Major Manufacturers of Primary Liver Cancer Table 30. Major Manufacturers of Others Table 31. Global TACE Embolic Microspheres Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global TACE Embolic Microspheres Sales by Application (2021-2026) & (K Units) Table 33. Global TACE Embolic Microspheres Sales by Application (2027-2032) & (K Units) Table 34. Global TACE Embolic Microspheres Sales Market Share by Application (2021-2026) Table 35. Global TACE Embolic Microspheres Sales Market Share by Application (2027-2032) Table 36. Global TACE Embolic Microspheres Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global TACE Embolic Microspheres Revenue by Application (2021-2026) & (K Units) Table 38. Global TACE Embolic Microspheres Revenue by Application (2027-2032) & (K Units) Table 39. Global TACE Embolic Microspheres Revenue Market Share by Application (2021-2026) Table 40. Global TACE Embolic Microspheres Revenue Market Share by Application (2027-2032) Table 41. Global TACE Embolic Microspheres Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global TACE Embolic Microspheres Sales by Region (2021-2026) & (K Units) Table 43. Global TACE Embolic Microspheres Sales Market Share by Region (2021-2026) Table 44. Global TACE Embolic Microspheres Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global TACE Embolic Microspheres Sales Forecasted Market Share by Region (2027-2032) Table 46. North America TACE Embolic Microspheres Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America TACE Embolic Microspheres Sales by Country (2021-2026) & (K Units) Table 48. North America TACE Embolic Microspheres Sales by Country (2027-2032) & (K Units) Table 49. Europe TACE Embolic Microspheres Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe TACE Embolic Microspheres Sales by Country (2021-2026) & (K Units) Table 51. Europe TACE Embolic Microspheres Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific TACE Embolic Microspheres Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific TACE Embolic Microspheres Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific TACE Embolic Microspheres Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa TACE Embolic Microspheres Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa TACE Embolic Microspheres Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa TACE Embolic Microspheres Sales by Country (2027-2032) & (K Units) Table 58. Global TACE Embolic Microspheres Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global TACE Embolic Microspheres Revenue by Region (2021-2026) & (US$ Million) Table 60. Global TACE Embolic Microspheres Revenue by Region (2027-2032) & (US$ Million) Table 61. Global TACE Embolic Microspheres Revenue Market Share by Region (2021-2026) Table 62. Global TACE Embolic Microspheres Revenue Market Share by Region (2027-2032) Table 63. ABK Biomedical Company Information Table 64. ABK Biomedical Business Overview Table 65. ABK Biomedical TACE Embolic Microspheres Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. ABK Biomedical TACE Embolic Microspheres Product Portfolio Table 67. ABK Biomedical Recent Development Table 68. Boston Scientific Company Information Table 69. Boston Scientific Business Overview Table 70. Boston Scientific TACE Embolic Microspheres Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Boston Scientific TACE Embolic Microspheres Product Portfolio Table 72. Boston Scientific Recent Development Table 73. Merit Medical Company Information Table 74. Merit Medical Business Overview Table 75. Merit Medical TACE Embolic Microspheres Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Merit Medical TACE Embolic Microspheres Product Portfolio Table 77. Merit Medical Recent Development Table 78. Mermaid Medical Company Information Table 79. Mermaid Medical Business Overview Table 80. Mermaid Medical TACE Embolic Microspheres Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Mermaid Medical TACE Embolic Microspheres Product Portfolio Table 82. Mermaid Medical Recent Development Table 83. Sirtex Medical Company Information Table 84. Sirtex Medical Business Overview Table 85. Sirtex Medical TACE Embolic Microspheres Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Sirtex Medical TACE Embolic Microspheres Product Portfolio Table 87. Sirtex Medical Recent Development Table 88. Terumo Company Information Table 89. Terumo Business Overview Table 90. Terumo TACE Embolic Microspheres Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Terumo TACE Embolic Microspheres Product Portfolio Table 92. Terumo Recent Development Table 93. Varian Company Information Table 94. Varian Business Overview Table 95. Varian TACE Embolic Microspheres Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Varian TACE Embolic Microspheres Product Portfolio Table 97. Varian Recent Development Table 98. Cardiolink Science Company Information Table 99. Cardiolink Science Business Overview Table 100. Cardiolink Science TACE Embolic Microspheres Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Cardiolink Science TACE Embolic Microspheres Product Portfolio Table 102. Cardiolink Science Recent Development Table 103. Suzhou Hengrui Medical Equipment Company Information Table 104. Suzhou Hengrui Medical Equipment Business Overview Table 105. Suzhou Hengrui Medical Equipment TACE Embolic Microspheres Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Suzhou Hengrui Medical Equipment TACE Embolic Microspheres Product Portfolio Table 107. Suzhou Hengrui Medical Equipment Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. TACE Embolic Microspheres Distributors List Table 111. TACE Embolic Microspheres Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. TACE Embolic Microspheres Product Image Figure 2. Global TACE Embolic Microspheres Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global TACE Embolic Microspheres Market Size (2021-2032) & (US$ Million) Figure 4. Global TACE Embolic Microspheres Sales (2021-2032) & (K Units) Figure 5. Global TACE Embolic Microspheres Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 TACE Embolic Microspheres Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Common Embolic Microspheres Image Figure 9. Drug-Loadable Embolic Microspheres Image Figure 10. Global TACE Embolic Microspheres Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global TACE Embolic Microspheres Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global TACE Embolic Microspheres Sales Market Share by Type (2021-2032) Figure 13. Global TACE Embolic Microspheres Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global TACE Embolic Microspheres Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global TACE Embolic Microspheres Revenue Market Share by Type (2021-2032) Figure 16. Colorectal Cancer Liver Metastasis Image Figure 17. Primary Liver Cancer Image Figure 18. Others Image Figure 19. Global TACE Embolic Microspheres Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global TACE Embolic Microspheres Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global TACE Embolic Microspheres Sales Market Share by Application (2021-2032) Figure 22. Global TACE Embolic Microspheres Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global TACE Embolic Microspheres Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global TACE Embolic Microspheres Revenue Market Share by Application (2021-2032) Figure 25. North America TACE Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America TACE Embolic Microspheres Sales Market Share by Country (2021-2032) Figure 27. U.S. TACE Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada TACE Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico TACE Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe TACE Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe TACE Embolic Microspheres Sales Market Share by Country (2021-2032) Figure 32. Germany TACE Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France TACE Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. TACE Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy TACE Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands TACE Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific TACE Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific TACE Embolic Microspheres Sales Market Share by Country (2021-2032) Figure 39. China TACE Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan TACE Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea TACE Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia TACE Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India TACE Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia TACE Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa TACE Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa TACE Embolic Microspheres Sales Market Share by Country (2021-2032) Figure 47. Brazil TACE Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa TACE Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia TACE Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey TACE Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina TACE Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE TACE Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt TACE Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile TACE Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global TACE Embolic Microspheres Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global TACE Embolic Microspheres Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America TACE Embolic Microspheres Revenue (2021-2032) & (US$ Million) Figure 58. North America TACE Embolic Microspheres Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe TACE Embolic Microspheres Revenue (2021-2032) & (US$ Million) Figure 60. Europe TACE Embolic Microspheres Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific TACE Embolic Microspheres Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific TACE Embolic Microspheres Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa TACE Embolic Microspheres Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa TACE Embolic Microspheres Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. TACE Embolic Microspheres Value Chain Figure 66. Manufacturing Cost Structure Figure 67. TACE Embolic Microspheres Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Common Embolic Microspheres
  • Drug-Loadable Embolic Microspheres
Applications
  • Colorectal Cancer Liver Metastasis
  • Primary Liver Cancer
  • Others
Companies covered
  • ABK Biomedical
  • Boston Scientific
  • Merit Medical
  • Mermaid Medical
  • Sirtex Medical
  • Terumo
  • Varian
  • Cardiolink Science
  • Suzhou Hengrui Medical Equipment

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global TACE Embolic Microspheres Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global TACE Embolic Microspheres Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global TACE Embolic Microspheres Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global TACE Embolic Microspheres Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global TACE Embolic Microspheres Market Dynamics
  1. 2.1 TACE Embolic Microspheres Industry Trends
  2. 2.2 TACE Embolic Microspheres Industry Drivers
  3. 2.3 TACE Embolic Microspheres Industry Opportunities and Challenges
  4. 2.4 TACE Embolic Microspheres Industry Restraints
3 TACE Embolic Microspheres Market by Manufacturers
  1. 3.1 Global TACE Embolic Microspheres Revenue by Manufacturers (2021-2026)
  2. 3.2 Global TACE Embolic Microspheres Sales by Manufacturers (2021-2026)
  3. 3.3 Global TACE Embolic Microspheres Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global TACE Embolic Microspheres Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global TACE Embolic Microspheres Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global TACE Embolic Microspheres Manufacturers, Product Type & Application
  7. 3.7 Global TACE Embolic Microspheres Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global TACE Embolic Microspheres Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 TACE Embolic Microspheres Players Market Share by Revenue in 2025
  11. 3.8.3 2025 TACE Embolic Microspheres Tier 1, Tier 2, and Tier 3
4 TACE Embolic Microspheres Market by Type
  1. 4.1 TACE Embolic Microspheres Type Introduction
  2. 4.1.1 Common Embolic Microspheres
  3. 4.1.2 Drug-Loadable Embolic Microspheres
  4. 4.2 Global TACE Embolic Microspheres Sales by Type
  5. 4.2.1 Global TACE Embolic Microspheres Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global TACE Embolic Microspheres Sales by Type (2021-2032)
  7. 4.2.3 Global TACE Embolic Microspheres Sales Market Share by Type (2021-2032)
  8. 4.3 Global TACE Embolic Microspheres Revenue by Type
  9. 4.3.1 Global TACE Embolic Microspheres Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global TACE Embolic Microspheres Revenue by Type (2021-2032)
  11. 4.3.3 Global TACE Embolic Microspheres Revenue Market Share by Type (2021-2032)
5 TACE Embolic Microspheres Market by Application
  1. 5.1 TACE Embolic Microspheres Application Introduction
  2. 5.1.1 Colorectal Cancer Liver Metastasis
  3. 5.1.2 Primary Liver Cancer
  4. 5.1.3 Others
  5. 5.2 Global TACE Embolic Microspheres Sales by Application
  6. 5.2.1 Global TACE Embolic Microspheres Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global TACE Embolic Microspheres Sales by Application (2021-2032)
  8. 5.2.3 Global TACE Embolic Microspheres Sales Market Share by Application (2021-2032)
  9. 5.3 Global TACE Embolic Microspheres Revenue by Application
  10. 5.3.1 Global TACE Embolic Microspheres Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global TACE Embolic Microspheres Revenue by Application (2021-2032)
  12. 5.3.3 Global TACE Embolic Microspheres Revenue Market Share by Application (2021-2032)
6 Global TACE Embolic Microspheres Sales by Region
  1. 6.1 Global TACE Embolic Microspheres Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global TACE Embolic Microspheres Sales by Region (2021-2032)
  3. 6.2.1 Global TACE Embolic Microspheres Sales by Region (2021-2026)
  4. 6.2.2 Global TACE Embolic Microspheres Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America TACE Embolic Microspheres Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America TACE Embolic Microspheres Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe TACE Embolic Microspheres Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe TACE Embolic Microspheres Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific TACE Embolic Microspheres Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific TACE Embolic Microspheres Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa TACE Embolic Microspheres Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa TACE Embolic Microspheres Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global TACE Embolic Microspheres Revenue by Region
  1. 7.1 Global TACE Embolic Microspheres Revenue by Region
  2. 7.1.1 Global TACE Embolic Microspheres Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global TACE Embolic Microspheres Revenue by Region (2021-2026)
  4. 7.1.3 Global TACE Embolic Microspheres Revenue by Region (2027-2032)
  5. 7.1.4 Global TACE Embolic Microspheres Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America TACE Embolic Microspheres Revenue (2021-2032)
  8. 7.2.2 North America TACE Embolic Microspheres Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe TACE Embolic Microspheres Revenue (2021-2032)
  11. 7.3.2 Europe TACE Embolic Microspheres Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific TACE Embolic Microspheres Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific TACE Embolic Microspheres Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa TACE Embolic Microspheres Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa TACE Embolic Microspheres Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 ABK Biomedical
  2. 8.1.1 ABK Biomedical Company Information
  3. 8.1.2 ABK Biomedical Business Overview
  4. 8.1.3 ABK Biomedical TACE Embolic Microspheres Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 ABK Biomedical TACE Embolic Microspheres Product Portfolio
  6. 8.1.5 ABK Biomedical Recent Developments
  7. 8.2 Boston Scientific
  8. 8.2.1 Boston Scientific Company Information
  9. 8.2.2 Boston Scientific Business Overview
  10. 8.2.3 Boston Scientific TACE Embolic Microspheres Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Boston Scientific TACE Embolic Microspheres Product Portfolio
  12. 8.2.5 Boston Scientific Recent Developments
  13. 8.3 Merit Medical
  14. 8.3.1 Merit Medical Company Information
  15. 8.3.2 Merit Medical Business Overview
  16. 8.3.3 Merit Medical TACE Embolic Microspheres Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merit Medical TACE Embolic Microspheres Product Portfolio
  18. 8.3.5 Merit Medical Recent Developments
  19. 8.4 Mermaid Medical
  20. 8.4.1 Mermaid Medical Company Information
  21. 8.4.2 Mermaid Medical Business Overview
  22. 8.4.3 Mermaid Medical TACE Embolic Microspheres Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Mermaid Medical TACE Embolic Microspheres Product Portfolio
  24. 8.4.5 Mermaid Medical Recent Developments
  25. 8.5 Sirtex Medical
  26. 8.5.1 Sirtex Medical Company Information
  27. 8.5.2 Sirtex Medical Business Overview
  28. 8.5.3 Sirtex Medical TACE Embolic Microspheres Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sirtex Medical TACE Embolic Microspheres Product Portfolio
  30. 8.5.5 Sirtex Medical Recent Developments
  31. 8.6 Terumo
  32. 8.6.1 Terumo Company Information
  33. 8.6.2 Terumo Business Overview
  34. 8.6.3 Terumo TACE Embolic Microspheres Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Terumo TACE Embolic Microspheres Product Portfolio
  36. 8.6.5 Terumo Recent Developments
  37. 8.7 Varian
  38. 8.7.1 Varian Company Information
  39. 8.7.2 Varian Business Overview
  40. 8.7.3 Varian TACE Embolic Microspheres Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Varian TACE Embolic Microspheres Product Portfolio
  42. 8.7.5 Varian Recent Developments
  43. 8.8 Cardiolink Science
  44. 8.8.1 Cardiolink Science Company Information
  45. 8.8.2 Cardiolink Science Business Overview
  46. 8.8.3 Cardiolink Science TACE Embolic Microspheres Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Cardiolink Science TACE Embolic Microspheres Product Portfolio
  48. 8.8.5 Cardiolink Science Recent Developments
  49. 8.9 Suzhou Hengrui Medical Equipment
  50. 8.9.1 Suzhou Hengrui Medical Equipment Company Information
  51. 8.9.2 Suzhou Hengrui Medical Equipment Business Overview
  52. 8.9.3 Suzhou Hengrui Medical Equipment TACE Embolic Microspheres Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Suzhou Hengrui Medical Equipment TACE Embolic Microspheres Product Portfolio
  54. 8.9.5 Suzhou Hengrui Medical Equipment Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 TACE Embolic Microspheres Value Chain Analysis
  2. 9.1.1 TACE Embolic Microspheres Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 TACE Embolic Microspheres Production Mode & Process
  6. 9.2 TACE Embolic Microspheres Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 TACE Embolic Microspheres Distributors
  9. 9.2.3 TACE Embolic Microspheres Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst